Private Capital Group, LLC Blueprint Medicines Corp Transaction History
Private Capital Group, LLC
- $133 Million
- Q2 2022
A detailed history of Private Capital Group, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Private Capital Group, LLC holds 131 shares of BPMC stock, worth $12,112. This represents 0.01% of its overall portfolio holdings.
Number of Shares
131
Previous 260
49.62%
Holding current value
$12,112
Previous $17,000
58.82%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BPMC
# of Institutions
340Shares Held
62MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$615 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$605 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$543 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$299 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$227 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.52B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...